Physician profile
David Hao
NPI 1801323357
$16,205.94
in general payments reported to CMS, 2019-2025
12 companies · $675 in 2025
The $675 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,232 · 2022: $8,469 · 2023: $4,503 · 2024: $328 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,251 · Travel and Lodging: $2,219 · Education: $35.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,250.82 |
| Travel and Lodging | $2,218.65 |
| Education | $35.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,336.03 | 2021-2024 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbott Laboratories | $4,700.70 | 2021-2023 | Proclaim |
| Mml US, INC. | $2,838.89 | 2023 | Reactiv8 |
| Medtronic, INC. | $1,357.30 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Spr Therapeutics, INC | $301.91 | 2021-2025 | Sprint Pns System |
| Curonix LLC | $141.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $127.77 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $121.47 | 2025 | |
| Si-Bone, INC. | $112.13 | 2024 | |
| Siemens Medical Solutions USA, INC. | $92.95 | 2023 | |
| Nevro Corp. | $39.41 | 2021 | |
| Biotronik Nro, INC. | $35.62 | 2025 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.